Endoscopy Plus Limited 07943622 false 2023-03-01 2024-02-29 2024-02-29 The principal activity of the company is medical consultancy Digita Accounts Production Advanced 6.30.9574.0 true true 07943622 2023-03-01 2024-02-29 07943622 2024-02-29 07943622 core:RetainedEarningsAccumulatedLosses 2024-02-29 07943622 core:ShareCapital 2024-02-29 07943622 core:CurrentFinancialInstruments 2024-02-29 07943622 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 07943622 core:FurnitureFittingsToolsEquipment 2024-02-29 07943622 bus:SmallEntities 2023-03-01 2024-02-29 07943622 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 07943622 bus:FilletedAccounts 2023-03-01 2024-02-29 07943622 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 07943622 bus:RegisteredOffice 2023-03-01 2024-02-29 07943622 bus:Director1 2023-03-01 2024-02-29 07943622 bus:Director2 2023-03-01 2024-02-29 07943622 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 07943622 core:ComputerEquipment 2023-03-01 2024-02-29 07943622 core:FurnitureFittingsToolsEquipment 2023-03-01 2024-02-29 07943622 countries:AllCountries 2023-03-01 2024-02-29 07943622 2023-02-28 07943622 core:FurnitureFittingsToolsEquipment 2023-02-28 07943622 2022-03-01 2023-02-28 07943622 2023-02-28 07943622 core:RetainedEarningsAccumulatedLosses 2023-02-28 07943622 core:ShareCapital 2023-02-28 07943622 core:CurrentFinancialInstruments 2023-02-28 07943622 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 07943622 core:FurnitureFittingsToolsEquipment 2023-02-28 iso4217:GBP xbrli:pure

Registration number: 07943622

Endoscopy Plus Limited

Unaudited Filleted Financial Statements

for the Year Ended 29 February 2024

 

Endoscopy Plus Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 5

 

Endoscopy Plus Limited

Company Information

Directors

Dr F Wong

Dr L H Wong

Registered office

2 Station Road
Balsall Common
Coventry
CV7 7FL

Accountants

Ballards LLP
Chartered Accountants
Oakmoore Court
11C Kingswood Road
Hampton Lovett
Droitwich
Worcestershire
WR9 0QH

 

Endoscopy Plus Limited

(Registration number: 07943622)
Balance Sheet as at 29 February 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

1,842

2,761

Current assets

 

Debtors

5

10,422

11,990

Cash at bank and in hand

 

346,839

284,411

 

357,261

296,401

Creditors: Amounts falling due within one year

6

(23,885)

(13,827)

Net current assets

 

333,376

282,574

Net assets

 

335,218

285,335

Capital and reserves

 

Called up share capital

100

100

Retained earnings

335,118

285,235

Shareholders' funds

 

335,218

285,335

For the financial year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 24 July 2024 and signed on its behalf by:
 

.........................................
Dr F Wong
Director

.........................................
Dr L H Wong
Director

 
     
 

Endoscopy Plus Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

1

General information

The company is a private company limited by share capital, incorporated in UK.

The address of its registered office is:
2 Station Road
Balsall Common
Coventry
CV7 7FL

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Endoscopy Plus Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer equipment

33.3% reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2023 - 2).

 

Endoscopy Plus Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 March 2023

9,570

9,570

At 29 February 2024

9,570

9,570

Depreciation

At 1 March 2023

6,809

6,809

Charge for the year

919

919

At 29 February 2024

7,728

7,728

Carrying amount

At 29 February 2024

1,842

1,842

At 28 February 2023

2,761

2,761

5

Debtors

Current

2024
£

2023
£

Trade debtors

10,422

11,990

 

10,422

11,990

6

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Taxation and social security

18,329

12,688

Accruals and deferred income

900

900

Other creditors

4,656

239

23,885

13,827